Short-duration, submaximal intensity exercise stress combined with adenosine triphosphate decreases artifacts in myocardial perfusion single-photon emission computed tomography.
Adenosine Triphosphate
/ administration & dosage
Aged
Aged, 80 and over
Artifacts
Coronary Artery Disease
/ diagnostic imaging
Exercise Test
Female
Humans
Male
Middle Aged
Myocardial Perfusion Imaging
Organophosphorus Compounds
/ administration & dosage
Organotechnetium Compounds
/ administration & dosage
Predictive Value of Tests
Radiopharmaceuticals
/ administration & dosage
Reproducibility of Results
Single Photon Emission Computed Tomography Computed Tomography
Time Factors
Adenosine triphosphate
Artifacts
End-diastolic volume
Exercise
Myocardial perfusion imaging
Rate pressure product
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
07 10 2020
07 10 2020
Historique:
received:
08
06
2020
accepted:
30
09
2020
entrez:
8
10
2020
pubmed:
9
10
2020
medline:
2
2
2021
Statut:
epublish
Résumé
Myocardial perfusion single-photon emission computed tomography (SPECT) imaging with stress is a useful examination for detecting coronary artery disease. Since the presence of artifacts is remaining challenges, we aimed to define the minimum intensity of low-grade exercise stress levels combined with drug stress to reduce undesired artifacts and their related factors. We divided patients with suspicious coronary artery disease into 4 groups as follows: group A, adenosine triphosphate (ATP) for 6 min; group A + 25 W, ATP + 25 W exercise for 6 min; group A + 35 W, ATP + 35 W exercise for 6 min; group A + 45 W, ATP + 45 W exercise for 6 min) and enrolled only those whose summed stress scores were < 3. Undesired artifacts were evaluated on the basis of heart-to-liver activity (H/L) ratio and heart-to-10 pixels below the heart (H/below the H) ratio. The logarithmic values of H/L and H/below the H ratios were significantly higher in groups A + 35 W and A + 45 W than in group A (p < 0.05, each). In all the patients, the logarithmic values of H/L and H/below the H ratios positively correlated with the increment of rate pressure product (RPP, p = 0.002 and p = 0.005, respectively) after stress in the univariate analysis. The left ventricular end-diastolic volume (LVEDV) after stress (p = 0.002) negatively correlated with the logarithmic value of H/below the H ratio, but not H/L ratio. Although the increment of RPP was independently associated with the logarithmic values of both H/L (p = 0.001) and H/below the H ratios (p = 0.005), LVEDV was also independently associated with the logarithmic value of H/below the H ratio (p < 0.001) in multivariate regression analysis under adjusting with age and sex. ATP plus ≥35 W exercise stress for 6 min was useful for reducing undesired artifacts after stress in myocardial perfusion SPECT. LVEDV after stress in addition to the increment of RPP was independently associated with the H/below the H ratio, but not the H/L ratio.
Sections du résumé
BACKGROUND
Myocardial perfusion single-photon emission computed tomography (SPECT) imaging with stress is a useful examination for detecting coronary artery disease. Since the presence of artifacts is remaining challenges, we aimed to define the minimum intensity of low-grade exercise stress levels combined with drug stress to reduce undesired artifacts and their related factors.
METHODS
We divided patients with suspicious coronary artery disease into 4 groups as follows: group A, adenosine triphosphate (ATP) for 6 min; group A + 25 W, ATP + 25 W exercise for 6 min; group A + 35 W, ATP + 35 W exercise for 6 min; group A + 45 W, ATP + 45 W exercise for 6 min) and enrolled only those whose summed stress scores were < 3. Undesired artifacts were evaluated on the basis of heart-to-liver activity (H/L) ratio and heart-to-10 pixels below the heart (H/below the H) ratio.
RESULTS
The logarithmic values of H/L and H/below the H ratios were significantly higher in groups A + 35 W and A + 45 W than in group A (p < 0.05, each). In all the patients, the logarithmic values of H/L and H/below the H ratios positively correlated with the increment of rate pressure product (RPP, p = 0.002 and p = 0.005, respectively) after stress in the univariate analysis. The left ventricular end-diastolic volume (LVEDV) after stress (p = 0.002) negatively correlated with the logarithmic value of H/below the H ratio, but not H/L ratio. Although the increment of RPP was independently associated with the logarithmic values of both H/L (p = 0.001) and H/below the H ratios (p = 0.005), LVEDV was also independently associated with the logarithmic value of H/below the H ratio (p < 0.001) in multivariate regression analysis under adjusting with age and sex.
CONCLUSION
ATP plus ≥35 W exercise stress for 6 min was useful for reducing undesired artifacts after stress in myocardial perfusion SPECT. LVEDV after stress in addition to the increment of RPP was independently associated with the H/below the H ratio, but not the H/L ratio.
Identifiants
pubmed: 33028207
doi: 10.1186/s12872-020-01720-w
pii: 10.1186/s12872-020-01720-w
pmc: PMC7542686
doi:
Substances chimiques
Organophosphorus Compounds
0
Organotechnetium Compounds
0
Radiopharmaceuticals
0
technetium tc-99m tetrofosmin
42FOP1YX93
Adenosine Triphosphate
8L70Q75FXE
Types de publication
Comparative Study
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
438Références
J Nucl Cardiol. 2003 May-Jun;10(3):291-6
pubmed: 12794628
Cardiology. 2001;95(2):112-8
pubmed: 11423717
J Am Coll Cardiol. 1995 May;25(6):1300-9
pubmed: 7722125
J Nucl Med. 1991 Nov;32(11):2071-8
pubmed: 1941141
J Nucl Cardiol. 2000 Nov-Dec;7(6):584-9
pubmed: 11144473
Am J Cardiol. 1999 Aug 15;84(4):400-3
pubmed: 10468076
Am J Cardiol. 1995 Mar 15;75(8):568-72
pubmed: 7887379
J Nucl Cardiol. 2002 Mar-Apr;9(2):188-96
pubmed: 11986564
J Am Coll Cardiol. 1994 Feb;23(2):384-9
pubmed: 8294691
J Nucl Cardiol. 1999 Jul-Aug;6(4):389-96
pubmed: 10461605
J Nucl Med. 1995 Jan;36(1):133-9
pubmed: 7799067
Eur Heart J. 1988 Nov;9(11):1206-14
pubmed: 3234412
J Nucl Cardiol. 2001 Nov-Dec;8(6):652-9
pubmed: 11725261
J Am Coll Cardiol. 1998 Jun;31(7):1540-6
pubmed: 9626832
J Nucl Med. 1994 Feb;35(2):356-9
pubmed: 8295010
Am J Cardiol. 1988 Oct 1;62(10 Pt 1):799-802
pubmed: 3421182
J Cardiol. 2008 Aug;52(1):30-8
pubmed: 18639775
J Nucl Cardiol. 2017 Apr;24(2):429-433
pubmed: 26797919